University of Utah — Salt Lake City, Utah

Public research footprint of University of Utah, compiled from the ClinicalTrials.gov public registry.

3,403

Registered studies

1,061

Active

534

Recruiting now

1,757

Completed

474

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Metastatic Malignant Solid Neoplasm · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT05687110 — Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With… (Recruiting)
NCT04380311 — Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant (Completed)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Utah?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.